FAQ

L 366509

Known as: L-366,509 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-1999
0119921999

Related topics

Related topics

2 relations

Broader (2)

PiperidinesSpiro Compounds

Related mentions per year

Related mentions per year

1946-2018
19401960198020002020
L 366509
Piperidines
Spiro Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Role of oxytocin in the initiation of term and preterm labor in rats: changes in oxytocin receptor density and plasma oxytocin concentration and the effect of an oxytocin antagonist, L-366,509.
OBJECTIVE Our purpose was to compare the functional roles of oxytocin in term and preterm labor in rats by both biochemical and… (More)
Is this relevant?
1994
1994
1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin…
Modifications to the previously reported spiroindenylpiperidine camphor-sulfonamide oxytocin (OT) antagonist L-366,509 have… (More)
Is this relevant?
1993
1993
Identification of an orally active, nonpeptidyl oxytocin antagonist.
L-366,509, a member of a novel class of nonpeptidyl compounds, has been characterized as an orally active oxytocin (OT… (More)
Is this relevant?
1993
1993
Nanomolar-affinity, non-peptide oxytocin receptor antagonists.
Non-peptide antagonists of the peptide hormone oxytocin (OT) with nanomolar OT receptor affinities are described. These compounds… (More)
Is this relevant?
1992
1992
Orally active, nonpeptide oxytocin antagonists.
The first nonpeptide antagonists of the neurohypophyseal hormone, oxytocin (OT) are described. Derivatives of the… (More)
Is this relevant?